Panacea Acquisition Corp. II

No Longer Reporting

The company has not filed an annual or quarterly report since its FY2022 10-K, filed Mar 30, 2023. Its latest SEC filing is a SC 13G/A from Feb 14, 2024.

The sections below describe the company as of the FY2022 annual report.

What Did They Do?

Seeks to combine with a biotechnology business and build it into a public company, focusing on potential targets in North America or Europe.

How Did They Make Money?

No revenue was reported.

How Were They Changing?

Since the FY2022 annual report

Apr 10, 2023 Missed the business-combination deadline and announced redemption of public shares It planned to redeem all public shares and expected Nasdaq to seek delisting.

Financial Snapshot

Last updated: 10/30/2026

Size 2021

Revenue: $0.00
Net Income: -$736.3K

Growth

Revenue Growth: N/A
EPS Growth: N/A

Profitability

Gross Margin
Operating Margin
Net Income Margin

Cash flow

Free Cash Flow

Balance sheet

Cash: N/A
Debt to Equity: N/A

Valuation On Apr 19, 2023

Market Cap: $241.10M
P/E

Company Facts

Industry: Blank Checks
Incorporated
Headquarters

Comments